Daniel Hynes is Currently Director, Preclinical Development at Destiny Pharma plc Oxford, United Kingdom. He worked as the Preclinical Manager at e-therapeutics PLC for 4 years. Hynes has got 4 Years work experience as Senior Scientist (ADME) at Evotec Pharmaceuticals. He got his degree from University of Leeds, UK.
Drug discovery and development, Pharmacology, Toxicology, ADME and Bioanalytical studies.
Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA.
His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry.